Apyx Medical (APYX) Change in Acquisitions & Divestments (2018 - 2019)

Apyx Medical (APYX) reported Change in Acquisitions & Divestments of $40.9 million for Q2 2019, up 2.62% quarter-over-quarter from $39.8 million in Q1 2019.

Apyx Medical (APYX) Change in Acquisitions & Divestments (2018 - 2019) Analysis & Trends

Apyx Medical has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $40.9 million in Q2 2019.

  • For the quarter ending Q2 2019, Change in Acquisitions & Divestments changed N/A year-over-year to $40.9 million; the trailing twelve-month figure through Mar 2020 stood at $40.9 million (down 37.68% YoY), and the FY2019 full-year result was $80.7 million, up 213.4% from the prior year.
  • Change in Acquisitions & Divestments for Q2 2019 stood at $40.9 million, up from $39.8 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $40.9 million in Q2 2019, with the low at $25.8 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Apyx Medical 205.37 Mn 174.49 Mn 7.93 Mn

Historic Data

Download Data
DateValue
Jun 30, 2019 40.88 Mn
Jun 30, 2019 40.88 Mn
Mar 31, 2019 39.84 Mn
Mar 31, 2019 39.84 Mn
Dec 31, 2018 25.76 Mn
Dec 31, 2018 25.76 Mn